Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | 7 Parkinson's trials, 2 stopped | 0.77 |
| literature PubMed | 33 Parkinson's papers of 4,451 | 0.54 |
| pathways Reactome | 9 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 4951
Sealed predictions
- EMD in dopamine neurons, braak+0.37 (p 0.321) → -0.55 (p 0.121)receipt 4958
Swarm cases
receipt 4958: EMD in dopamine neurons, braak
- power
- full sample -0.03 (p 0.894, n 18), 95% CI -0.49 to +0.44. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.16 (p 0.538, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.24 (p 0.341, n 18). could be the mix.
- skeptic
- leave-one-out range -0.17 to +0.12, sign flips 5; without severely affected donors -0.03 (p 0.894, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for EMD in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts